Cytodyn Inc (CYDY)

[The Lawman]

Even Pourhassan's most staunch supporters have gone silent: better late than never.

I guess the emails to Amarex were too much for even Pourhassan's long-time apologists to explain and tolerate.

Let's hope the next CEO can get respect from the FDA, as well as from possible collaborators and investors, that is not possible under Pourhassan, in my opinion.

When Pourhassan is finally dispatched, I expect the share price to increase dramatically, and for Cytodyn and leronlimab to finally get the respect they deserve.

The world needs leronlimab, and Cytodyn desperately needs a change of management.

LM